ArticleBioengineering & translational medicine2021

Targeting thymidine phosphorylase as a potential therapy for bone loss associated with periprosthetic osteolysis.

Gen Matsumae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.